Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ITClinic ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 5.4% 5.4%   Bankruptcy risk   5.3% 4.2% 6.7% 4.6% 3.3% 4.5% 16.2% 16.2%   Credit score (0-100)   43 50 35 44 55 46 11 11   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   533 164 162 387 201 235 0.0 0.0   EBITDA   277 85.1 19.7 265 196 178 0.0 0.0   EBIT   243 29.5 -34.5 207 176 142 0.0 0.0   Pre-tax profit (PTP)   243.0 6.1 -42.0 201.4 173.9 140.0 0.0 0.0   Net earnings   190.4 31.4 -47.2 177.1 135.5 112.8 0.0 0.0   Pre-tax profit without non-rec. items   243 6.1 -42.0 201 174 140 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   56.3 318 293 246 98.4 80.9 0.0 0.0   Shareholders equity total   279 310 163 290 320 311 139 139   Interest-bearing liabilities   0.0 222 174 64.6 0.0 0.0 0.0 0.0   Balance sheet total (assets)   459 646 575 569 485 430 139 139   Net Debt   -39.6 210 121 1.8 -174 -31.3 -139 -139     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   533 164 162 387 201 235 0.0 0.0   Gross profit growth   -4.0% -69.3% -1.3% 139.6% -48.1% 16.8% -100.0% 0.0%   Employees   0 0 0 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   459 646 575 569 485 430 139 139   Balance sheet change%   86.3% 40.6% -10.9% -1.0% -14.8% -11.4% -67.6% 0.0%   Added value   277.1 85.1 19.7 265.5 234.6 178.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -4 207 -79 -106 -167 -54 -81 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   45.6% 18.0% -21.4% 53.5% 87.7% 60.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   68.9% 5.3% -5.6% 36.2% 33.5% 31.0% 0.0% 0.0%   ROI %   132.2% 7.2% -7.7% 58.0% 50.7% 43.4% 0.0% 0.0%   ROE %   103.9% 10.7% -20.0% 78.3% 44.4% 35.8% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   60.7% 48.0% 28.3% 50.9% 66.0% 72.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -14.3% 246.9% 616.6% 0.7% -89.1% -17.6% 0.0% 0.0%   Gearing %   0.0% 71.7% 107.3% 22.3% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 21.1% 4.0% 4.8% 8.1% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.2 0.2 0.4 0.5 1.3 1.7 0.0 0.0   Current Ratio   2.1 2.8 1.2 1.5 2.5 3.2 0.0 0.0   Cash and cash equivalent   39.6 12.2 53.2 62.8 174.4 31.3 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   196.9 196.5 36.2 107.0 225.0 235.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 178 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 178 0 0   EBIT / employee   0 0 0 0 0 142 0 0   Net earnings / employee   0 0 0 0 0 113 0 0